Aggressive Juvenile-Onset Respiratory Papillomatosis in a High HIV Prevalence Setting: Clinical Predictors of Severity in South Africa - Takeaways - MDSpire

Aggressive Juvenile-Onset Respiratory Papillomatosis in a High HIV Prevalence Setting: Clinical Predictors of Severity in South Africa

  • By

  • L A Sibiya

  • T Abel

  • S Maistry

  • R Seedat

  • J Z Porterfield

  • Y Liang

  • E Evangelista

  • M Tyle

  • Y Saman

  • N Msomi

  • December 15, 2025

  • 0 min

Share

  • 1

    Juvenile-onset recurrent respiratory papillomatosis (JoRRP) has a prevalence of 4.17 per 100,000 population in South Africa, with a median diagnosis age of 4 years.

  • 2

    Half of the JoRRP patients studied exhibited aggressive disease, with younger children (≤2 years) at higher risk compared to older age groups.

  • 3

    Exposure to maternal HIV significantly correlates with pulmonary involvement in JoRRP patients, highlighting the impact of maternal health on child outcomes.

  • 4

    Aggressive JoRRP is characterized by rapid papilloma growth and frequent surgeries, necessitating early recognition for effective management.

  • 5

    The study emphasizes the need for integrated maternal-child healthcare and public health interventions to address JoRRP in high HIV-prevalence regions.

Original Source(s)

Aggressive Juvenile-Onset Respiratory Papillomatosis in a High HIV Prevalence Setting: Clinical Predictors of Severity in South Africa

  • by L A Sibiya, T Abel, S Maistry, R Seedat, J Z Porterfield, Y Liang, E Evangelista, M Tyle, Y Saman, N Msomi

  • December 15, 2025

Related Content

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

Medical Oddities: Can a Home Be Preventive Care?

This week’s medical plot twists involved ants, architecture, and auditory hallucinations.

FDA Clears AI Sepsis Warning System

An FDA-cleared AI tool developed at Johns Hopkins detects sepsis up to 48 hours earlier than clinicians — and has cut related deaths by 18%.